Clinical trial

H-Type Hypertension Precision Medicine Trial

NCT03472508

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2018-03-20

PhasePHASE4

Study timeline

Study start (actual)2018-03-20Date precision: day

Registry last updated2018-07-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

Folic AcidDRUG · verified · RxNorm: folic acid

Enalapril Maleate and Folic Acid Tablets (Yiye)DRUG

EnalaprilDRUG · verified · RxNorm: enalapril

Sponsors & collaborators

Shenzhen Ausa Pharmed Co.,Ltdlead sponsor

Second Affiliated Hospital of Nanchang Universitycollaborator

Shenzhen Evergreen Medical Institutecollaborator

Nanfang Hospital, Southern Medical Universitycollaborator

Peking University First Hospitalcollaborator

The First People's Hospital of Lianyungangcollaborator

People's Hospital of Rongchengcollaborator

Anhui Medical Universitycollaborator

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03472508 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.